Understanding the role of non-coding RNA (ncRNA) in stent restenosis

Shaoyan Liu1, Yanyan Yang2, Shaoyan Jiang3

  • 1Department of Cardiology, The Affiliated Hospital of Qingdao University, 266000, People's Republic of China.

Atherosclerosis
|April 3, 2018
PubMed

Insights

Coronary heart disease treatments like stents can cause complications. Non-coding RNAs (ncRNAs) show promise in regulating vascular responses and may offer new targets to prevent stent restenosis and thrombosis.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biomedical Engineering

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality.
  • Percutaneous coronary intervention with stent implantation is standard treatment for obstructive coronary artery disease.
  • Stents, as foreign bodies, can trigger vascular smooth muscle cell proliferation, immune responses, and neointima formation, leading to post-stent restenosis (ISR) and late thrombosis.

Purpose of the Study:

  • To review the regulatory roles of non-coding RNAs (ncRNAs) in cardiovascular disease.
  • To explore the potential of ncRNAs as therapeutic targets for preventing adverse vascular events after stent implantation.

Main Methods:

  • Literature review of studies on ncRNAs and cardiovascular disease.
  • Analysis of ncRNA regulatory mechanisms in vascular cells and inflammatory processes.
  • Synthesis of current knowledge on ncRNAs in the context of coronary stenting.

Main Results:

  • Non-coding RNAs (ncRNAs) are key regulators of endothelial and vascular smooth muscle cell function.
  • ncRNAs play significant roles in modulating inflammatory reactions relevant to cardiovascular pathology.
  • Specific ncRNAs have been implicated in the processes leading to ISR and thrombosis.

Conclusions:

  • ncRNAs represent a novel class of molecules with significant potential in cardiovascular disease regulation.
  • Targeting ncRNAs may offer a promising therapeutic strategy to prevent stent-related complications like ISR and thrombosis.
  • Further research into ncRNA mechanisms could lead to improved outcomes for patients undergoing coronary stenting.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.4K
Understanding the Self01:28

Understanding the Self

The self is a central aspect of human identity, encompassing an individual’s beliefs, emotions, perceptions, and experiences. It is a cognitive and psychological construct that enables individuals to interpret their traits and behaviors, influencing how they perceive themselves and interact with the world. While personality consists of stable and enduring characteristics, the self is shaped by self-perception and social experiences. This distinction highlights the dynamic nature of the...
324
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.7K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.9K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.8K